Stockscreener 앱 받기
8.93
1.36%
0.12
전일 마감가:
$8.81
열려 있는:
$8.85
하루 거래량:
2.05M
Relative Volume:
0.91
시가총액:
$1.55B
수익:
$25.55M
순이익/손실:
$-341.97M
주가수익비율:
-3.1893
EPS:
-2.8
순현금흐름:
$-304.44M
1주 성능:
+0.11%
1개월 성능:
+12.47%
6개월 성능:
+161.11%
1년 성능:
+125.51%
1일 변동 폭
$8.85
$9.54
1주일 범위
$8.35
$9.54
52주 변동 폭
$1.775
$9.54
릴레이 테라퓨틱스 Stock (RLAY) Company Profile
명칭
Relay Therapeutics Inc
전화
617-370-8837
주소
60 HAMPSHIRE STREET, CAMBRIDGE
Compare RLAY vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RLAY
Relay Therapeutics Inc
|
8.93 | 1.53B | 25.55M | -341.97M | -304.44M | -2.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.47 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.17 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
821.96 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.40 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.07 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
릴레이 테라퓨틱스 Stock (RLAY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-26 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2025-12-12 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2025-09-04 | 재개 | Guggenheim | Buy |
| 2025-04-17 | 개시 | Wells Fargo | Equal Weight |
| 2024-09-10 | 재개 | Goldman | Buy |
| 2024-09-10 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-09-10 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-05-10 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2023-04-20 | 업그레이드 | Jefferies | Underperform → Hold |
| 2023-04-19 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-04-13 | 개시 | Raymond James | Outperform |
| 2023-02-03 | 개시 | Oppenheimer | Outperform |
| 2022-09-30 | 개시 | Barclays | Equal Weight |
| 2022-09-02 | 개시 | Stifel | Buy |
| 2022-06-06 | 개시 | Jefferies | Underperform |
| 2022-02-01 | 개시 | Berenberg | Buy |
| 2021-07-21 | 개시 | BofA Securities | Buy |
| 2020-12-15 | 재확인 | H.C. Wainwright | Buy |
| 2020-12-08 | 개시 | JMP Securities | Mkt Outperform |
| 2020-11-05 | 개시 | H.C. Wainwright | Buy |
| 2020-08-10 | 개시 | Cowen | Outperform |
| 2020-08-10 | 개시 | Goldman | Buy |
| 2020-08-10 | 개시 | Guggenheim | Buy |
| 2020-08-10 | 개시 | JP Morgan | Neutral |
모두보기
릴레이 테라퓨틱스 주식(RLAY)의 최신 뉴스
Will Relay Therapeutics Inc. benefit from government policy2025 Price Targets & Free Community Supported Trade Ideas - mfd.ru
Can Relay Therapeutics Inc. expand its profit marginsPortfolio Update Report & Weekly Watchlist of Top Performers - mfd.ru
Can Relay Therapeutics Inc. sustain its profitability2025 Bull vs Bear & Low Risk High Reward Trade Ideas - mfd.ru
Relay Therapeutics stock hits 52-week high at $9.16 By Investing.com - Investing.com South Africa
Relay Therapeutics (NASDAQ:RLAY) Sets New 12-Month HighTime to Buy? - MarketBeat
Relay Therapeutics stock hits 52-week high at $9.16 - Investing.com
Assessing Relay Therapeutics (RLAY) Valuation After Recent Share Price Momentum And Price To Book Discount - Sahm
Assessing Relay Therapeutics (RLAY) Valuation After FDA Breakthrough Therapy Designation For Zovegalisib - Yahoo Finance
Relay Therapeutics Insider Sells 21,000 Shares for $166,700 After 65% Run - The Globe and Mail
$207B Market Shift: The Race for Fast Track Approval in Oncology - Investing News Network
$207B Market Shift: The Race for Fast Track Approval in Oncology - Benzinga
Relay Therapeutics to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026 - Investing News Network
Relay Thera’s zovegalisib wins ‘Breakthrough’ status from FDA - The Pharma Letter
Relay Therapeutics announces Zovegalisib granted therapy designation by FDA for PIK3CA-mutant - marketscreener.com
Relay Therapeutics stock rises after FDA grants Breakthrough Therapy status By Investing.com - Investing.com South Africa
Relay Therapeutics stock rises after FDA grants Breakthrough Therapy status - Investing.com
Relay Therapeutics Announces Breakthrough Therapy Designation for Zovegalisib - TradingView
Relay Therapeutics Announces Zovegalisib Granted - GlobeNewswire
Relay Therapeutics Announces Zovegalisib Granted Breakthrough Therapy Designation by U.S. FDA for PIK3CA-mutant, HR+/HER2- Advanced Breast Cancer - The Manila Times
Aug Retail: Can Relay Therapeutics Inc sustain its profitabilityProfit Target & Step-by-Step Swing Trade Plans - baoquankhu1.vn
Oppenheimer Notes Relay Therapeutics, Inc. (RLAY) Pipeline Strength in Mutant-Selective Inhibitors - Finviz
Relay Therapeutics (NASDAQ:RLAY) Shares Up 7.2%Here's Why - MarketBeat
Oppenheimer Notes Relay Therapeutics (RLAY) Pipeline Strength in Mutant-Selective Inhibitors - Yahoo Finance
Rate Cut: Is Relay Therapeutics Inc a speculative investmentPortfolio Gains Report & Consistent Profit Alerts - baoquankhu1.vn
Movement Recap: Will Relay Therapeutics Inc benefit from government policyWeekly Profit Recap & Free Technical Pattern Based Buy Signals - baoquankhu1.vn
Relay Therapeutics, Inc. (RLAY) Stock Analysis: Exploring an 88.66% Potential Upside in the Biotech Sector - DirectorsTalk Interviews
Relay Therapeutics (RLAY) Valuation Check After Analyst Upgrades And Zovegalisib Breast Cancer Data - Sahm
Relay Therapeutics president sells $166k in RLAY stock By Investing.com - Investing.com Australia
Moving Averages: Is Trex Company Inc stock a buy or sellTrade Analysis Summary & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
Guidance Update: Can Relay Therapeutics Inc reach all time highs this year - baoquankhu1.vn
Relay Therapeutics (NASDAQ:RLAY) Insider Donald Bergstrom Sells 2,686 Shares - MarketBeat
Relay Therapeutics (NASDAQ:RLAY) Insider Sells $11,441.30 in Stock - MarketBeat
Insider Selling: Relay Therapeutics (NASDAQ:RLAY) CFO Sells 1,695 Shares of Stock - MarketBeat
Insider Selling: Relay Therapeutics (NASDAQ:RLAY) Insider Sells 11,684 Shares of Stock - MarketBeat
Thomas Catinazzo Sells 13,820 Shares of Relay Therapeutics (NASDAQ:RLAY) Stock - MarketBeat
Rahmer Peter, chief corporate development officer at Relay Therapeutics, sells $100k in shares - Investing.com Canada
Relay Therapeutics president sells $166k in RLAY stock - Investing.com
Relay Therapeutics (NASDAQ:RLAY) Stock Price Down 6.7%Should You Sell? - MarketBeat
Trend Recap: What is the Moat Score of REGNJuly 2025 Setups & Technical Pattern Alert System - baoquankhu1.vn
Oppenheimer Upgrade Fuels Relay Therapeutics Rally On Zovegalisib Optimism (NASDAQ:RLAY) - Seeking Alpha
Relay Therapeutics shares climb after Oppenheimer lifts rating - MSN
Relay Therapeutics (NASDAQ:RLAY) Trading Up 8.4%Here's Why - MarketBeat
Oppenheimer Upgrades Relay Therapeutics (RLAY) with Positive Out - GuruFocus
Oppenheimer Upgrades Relay Therapeutics (RLAY) - Nasdaq
Oppenheimer upgrades Relay Therapeutics stock rating on gedatolisib concerns By Investing.com - Investing.com Canada
Relay Therapeutics (RLAY) Upgraded by Oppenheimer, Price Target Set at $14.00 | RLAY Stock News - GuruFocus
Relay Therapeutics stock rises after Oppenheimer upgrade By Investing.com - Investing.com Nigeria
릴레이 테라퓨틱스 (RLAY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
릴레이 테라퓨틱스 주식 (RLAY) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Bergstrom Donald A | President, R&D |
Jan 28 '26 |
Sale |
8.45 |
2,686 |
22,697 |
420,047 |
| Rahmer Peter | See remarks |
Jan 27 '26 |
Sale |
7.62 |
11,684 |
89,032 |
277,964 |
| Rahmer Peter | See remarks |
Jan 28 '26 |
Sale |
8.45 |
1,354 |
11,441 |
276,610 |
| Catinazzo Thomas | Chief Financial Officer |
Jan 27 '26 |
Sale |
7.62 |
13,820 |
105,308 |
250,996 |
| Catinazzo Thomas | Chief Financial Officer |
Jan 28 '26 |
Sale |
8.45 |
1,695 |
14,323 |
249,301 |
| Patel Sanjiv | President and CEO |
Jan 06 '26 |
Sale |
7.82 |
43,168 |
337,574 |
661,041 |
| Patel Sanjiv | President and CEO |
Nov 03 '25 |
Sale |
7.00 |
62,073 |
434,511 |
703,215 |
| Rahmer Peter | See remarks |
Oct 29 '25 |
Sale |
7.50 |
21,394 |
160,455 |
337,469 |
| Rahmer Peter | See remarks |
Oct 28 '25 |
Sale |
7.29 |
19,135 |
139,494 |
358,863 |
| Catinazzo Thomas | Chief Financial Officer |
Oct 28 '25 |
Sale |
7.29 |
21,664 |
157,931 |
313,631 |
1.12%
0.87%
자본화:
|
볼륨(24시간):